GSK plc GSK
NYSE GSK
$46.50 -0.02 (-0.04%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gsk (GSK) Liabilities from Discontinued Operations (2022 - 2025)

Updated

Gsk's Liabilities from Discontinued Operations came in at $182.6 million for the quarter ended Sep 8, 2026.

Analysis

Gsk (GSK) Liabilities from Discontinued Operations (2022 - 2025) Analysis & Trends

As of Dec 31, 2025, Gsk's Liabilities from Discontinued Operations was -$183.27 million.

  • Going back by year, Liabilities from Discontinued Operations was $3.77 billion in the year ended Dec 31, 2022 (+73.6%) and $2.17 billion in the year ended Dec 31, 2021.
  • The figure for the quarter ended Sep 8, 2026 represents the highest quarterly Liabilities from Discontinued Operations since the quarter ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn
10 Gsk 100.33 Bn 81.91 Bn 8.24 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -184.89 Mn
Jun 30, 2022 -22.48 Bn
API Access

Gsk Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=GSK&period=max&api_key=YOUR_API_KEY